The Feasibility of Detecting Neuropsychologic and Neuroanatomic Effects of Type 1 Diabetes in Young Children
Overview
Authors
Affiliations
Objective: To determine if frequent exposures to hypoglycemia and hyperglycemia during early childhood lead to neurocognitive deficits and changes in brain anatomy.
Research Design And Methods: In this feasibility, cross-sectional study, young children, aged 3 to 10 years, with type 1 diabetes and age- and sex-matched healthy control (HC) subjects completed neuropsychologic (NP) testing and magnetic resonance imaging (MRI) scans of the brain.
Results: NP testing and MRI scanning was successfully completed in 98% of the type 1 diabetic and 93% of the HC children. A significant negative relationship between HbA1c and Wechsler Intelligence Scale for Children (WISC) verbal comprehension was observed. WISC index scores were significantly reduced in type 1 diabetic subjects who had experienced seizures. White matter volume did not show the expected increase with age in children with type 1 diabetes compared with HC children (diagnosis by age interaction, P=0.005). A similar trend was detected for hippocampal volume. Children with type 1 diabetes who had experienced seizures showed significantly reduced gray matter and white matter volumes relative to children with type 1 diabetes who had not experienced seizures.
Conclusions: It is feasible to perform MRI and NP testing in young children with type 1 diabetes. Further, early signs of neuroanatomic variation may be present in this population. Larger cross-sectional and longitudinal studies of neurocognitive function and neuroanatomy are needed to define the effect of type 1 diabetes on the developing brain.
Litmanovitch E, Geva R, Leshem A, Lezinger M, Heyman E, Gidron M Front Endocrinol (Lausanne). 2023; 14:1141085.
PMID: 37091855 PMC: 10113499. DOI: 10.3389/fendo.2023.1141085.
Urakami T J Clin Med. 2023; 12(3).
PMID: 36769430 PMC: 9917934. DOI: 10.3390/jcm12030781.
Abraham M, Karges B, Dovc K, Naranjo D, Arbelaez A, Mbogo J Pediatr Diabetes. 2022; 23(8):1322-1340.
PMID: 36537534 PMC: 10107518. DOI: 10.1111/pedi.13443.
Epilepsy, Immunity and Neuropsychiatric Disorders.
Fortunato F, Giugno A, Sammarra I, Labate A, Gambardella A Curr Neuropharmacol. 2022; 21(8):1714-1735.
PMID: 35794773 PMC: 10514543. DOI: 10.2174/1570159X20666220706094651.
Urakami T, Terada H, Yoshida K, Kuwabara R, Mine Y, Aoki M J Diabetes Investig. 2022; 13(10):1745-1752.
PMID: 35532954 PMC: 9533045. DOI: 10.1111/jdi.13830.